FDA Approves First Treatment for MAS in Still Disease ...Middle East

News by : (Medscape) -
Emapalumab is approved for both adults and pediatric (newborn and older) patients with MAS in Still disease with an inadequate response or intolerance to glucocorticoids, or with recurrent MAS. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First Treatment for MAS in Still Disease )

Also on site :

Most Viewed News
جديد الاخبار